Illuminant Surgical has been selected to participate in Y Combinator's S22 Batch.
For the Summer 2022 batch, YC received 19,000 applications from founders around the world and funded 240. Additionally, only 9% of the batch are healthcare companies. We will present to an invite-only audience of investors at YC's 35th Demo Day.
We are excited to work with our partners at YC to help bring our product to patients!
Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.
Similar Articles
Never miss an update.
Stay up-to-date with everything Illuminant. We’ll never send you spam.